0
0
8/8/23 at 11:36am
Organization
CNBC
Author
Sam Meredith
46 words
0
Comments
The results of the trial were seen as a major boost for the firm's hopes of moving beyond Wegovy's image as a "vanity drug."
You are the first to view
https://www.cnbc.com/2023/08/08/wegovy-novo-nordisk-shares-pop-after-trial-data-exceeds-expectations.html
Create an account
or login to join the discussion